Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × NIH × ceralasertib × Clear all

Phase

Phase 3 1 Phase 2 1 Phase 1 1

Status

Active not recruiting 1

Sponsor Class

NIH 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Cyclophosphamide 110 Radiotherapy 106 Fluorouracil 76 Doxorubicin 75 Carboplatin 71 Etoposide 68 Vincristine 67 Cisplatin 67 Paclitaxel 58 Chemotherapy, Adjuvant 53 Leucovorin 47 Specimen Handling 43 Cytarabine 42 Magnetic Resonance Spectroscopy 38 Methotrexate 37 Dexamethasone 33 Taxes 31 Bevacizumab 31 Peripheral Blood Stem Cell Transplantation 30 Gemcitabine 30 Filgrastim 30 Docetaxel 30 Tamoxifen 28 Melphalan 28 Immunoglobulin G 25 Epirubicin 25 Disulfides 25 Prednisone 24 Oxaliplatin 24 Daunorubicin 24

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06732401 2026-04-13

CLEAR

National Cancer Institute (NCI)

Phase 3 Active not recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡